Market Research Logo

United States Incontinence Devices Market Outlook to 2023

United States Incontinence Devices Market Outlook to 2023

Summary



GlobalData’s new report, United States Incontinence Devices Market Outlook to 2023, provides key market data on the United States Incontinence Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Protective Garments for Incontinence, Urinary Catheters and Urine Bags.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Incontinence Devices market segments - Protective Garments for Incontinence, Urinary Catheters and Urine Bags.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Incontinence Devices market.
  • Key players covered include Kimberly-Clark Corporation, Cardinal Health Inc, First Quality Enterprises Inc, Svenska Cellulosa Aktiebolaget and Medtronic plc.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Incontinence Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Incontinence Devices Market, United States 8
3.1 Incontinence Devices Market, United States, Revenue ($m), 2009-2016 8
3.2 Incontinence Devices Market, United States, Revenue ($m), 2016-2023 10
3.2.1 Protective Garments for Incontinence Market, United States, Revenue ($m), by Segment, 2009-2016 12
3.2.2 Urinary Catheters Market, United States, Revenue ($m), by Segment, 2009-2016 14
3.2.3 Protective Garments for Incontinence Market, United States, Revenue ($m), by Segment, 2016-2023 16
3.2.4 Urinary Catheters Market, United States, Revenue ($m), by Segment, 2016-2023 18
3.3 Incontinence Devices Market, United States, Volume (Units), 2009-2016 20
3.4 Incontinence Devices Market, United States, Volume (Units), 2016-2023 22
3.4.1 Protective Garments for Incontinence Market, United States, Volume (Units), by Segment, 2009-2016 24
3.4.2 Urinary Catheters Market, United States, Volume (Units), by Segment, 2009-2016 26
3.4.3 Protective Garments for Incontinence Market, United States, Volume (Units), by Segment, 2016-2023 28
3.4.4 Urinary Catheters Market, United States, Volume (Units), by Segment, 2016-2023 30
3.5 Incontinence Devices Market, United States, Average Price ($), 2009-2023 32
3.6 Incontinence Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016 34
3.7 Incontinence Devices Market, United States, Company Share by Revenue ($m), 2016 35
4 Overview of Key Companies in United States, Incontinence Devices Market 37
4.1 Kimberly-Clark Corporation 37
4.1.1 Company Overview 37
4.2 Cardinal Health Inc 37
4.2.1 Company Overview 37
4.3 First Quality Enterprises Inc 37
4.3.1 Company Overview 37
4.4 Svenska Cellulosa Aktiebolaget 37
4.4.1 Company Overview 37
4.5 Medtronic Plc 38
4.5.1 Company Overview 38
4.6 Teleflex Inc 38
4.6.1 Company Overview 38
4.7 Ontex Group N.V. 38
4.7.1 Company Overview 38
4.8 C. R. Bard Inc 38
4.8.1 Company Overview 38
4.9 Coloplast A/S 39
4.9.1 Company Overview 39
4.10 Hollister Incorporated 39
4.10.1 Company Overview 39
4.11 ConvaTec Group Plc 39
4.11.1 Company Overview 39
5 Incontinence Devices Market Pipeline Products 40
6 Financial Deals Landscape 41
6.1 Acquisition 41
6.1.1 Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 41
6.1.2 Ethicon Acquires Torax Medical 43
6.2 Equity Offerings 44
6.2.1 Zynex to Raise USD1.5 Million in Private Placement 44
6.2.2 ConvaTec Raises USD1.8 Billion in IPO 45
6.3 Venture Financing 47
6.3.1 Consortia Health Raises USD2 Million in Financing 47
6.3.2 Vesiflo Raises USD3.3 Million in Venture Financing 48
7 Recent Developments 49
7.1 Corporate Communications 49
7.1.1 Jun 09, 2017: Zynex Hires Chief Financial Officer 49
7.1.2 Apr 03, 2017: Minnesota Medical Announces David A. Jonas as Chief Financial Officer/Director 49
7.1.3 Mar 30, 2017: Gynesonics Names James Sparks Vice President of Manufacturing 49
7.1.4 Mar 01, 2017: Sientra Appoints Vidur Sahney as Vice President, Operations and Supply Chain 50
7.1.5 Feb 07, 2017: Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors 50
7.1.6 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 51
7.1.7 Sep 01, 2016: The Cooper Companies CFO Gregory W. Matz to Retire; Albert G. White Named Successor in Planned Transition 52
7.1.8 Sep 01, 2016: Verathon Announces the Appointment of Tracy Olson, Vice President of Finance 52
7.2 Financial Announcements 52
7.2.1 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 52
7.2.2 Jun 01, 2017: The Cooper Companies Announces Second Quarter 2017 Results 53
7.2.3 Jun 01, 2017: The Cooper Companies Announces Second Quarter 2017 Results 54
7.2.4 May 22, 2017: Agenus to present safety results for anti-CTLA-4 antibody at ASCO 2017 Annual Meeting 55
7.2.5 May 15, 2017: Zynex Announces 2017 First Quarter Results 56
7.2.6 May 09, 2017: Sientra Reports First Quarter 2017 Financial Results 56
7.2.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 57
7.2.8 Apr 23, 2017: Bard Announces First Quarter Results 58
7.2.9 Apr 18, 2017: Amgen Launches Neulasta (pegfilgrastim) Onpro NARRATIVES 59
7.2.10 Apr 03, 2017: Zynex Announces 2016 Year End Results 60
7.2.11 Mar 14, 2017: Sientra Reports Fourth Quarter and Full Year 2016 Financial Results 60
7.2.12 Mar 02, 2017: The Cooper Companies Announces First Quarter Results 61
7.2.13 Mar 01, 2017: Product launch of 4D Lifetest at the 56th Annual Meeting of the Society of Toxicology 62
7.2.14 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 63
7.2.15 Jan 30, 2017: Simavita Releases ASX Appendix 4C for the Quarter Ended December 31, 2016 64
7.2.16 Jan 26, 2017: Bard Announces Fourth Quarter Results 65
7.2.17 Dec 08, 2016: The Cooper Companies Announces Fourth Quarter and Full Year 2016 Results 65
7.2.18 Nov 10, 2016: Zynex Announces Third Quarter 2016 Profit 66
7.2.19 Nov 08, 2016: Sientra Reports Third Quarter 2016 Financial Results 67
7.2.20 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 68
7.2.21 Oct 25, 2016: Bard Announces Third Quarter Results 69
7.2.22 Sep 01, 2016: The Cooper Companies Announces Third Quarter 2016 Results 70
7.2.23 Aug 22, 2016: Zynex Announces Second Quarter 2016 Results 70
7.2.24 Aug 16, 2016: GlycoMimetics Announces Publication of Preclinical Data Showing Drug Candidate GMI-1271 Reduces Inflammatory Responses After Heart Attack 71
7.2.25 Aug 09, 2016: Sientra Reports Second Quarter 2016 Financial Results and Progress on Manufacturing Solution 71
7.3 Government and Public Interest 72
7.3.1 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures 72
7.4 Legal And Regulatory 73
7.4.1 Jun 28, 2017: Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy Reduces Rate of Pre-Term Preeclampsia 73
7.5 Other Significant Developments 74
7.5.1 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 74
7.5.2 May 16, 2017: HealthTrust Awards Hollister Incorporated Ostomy Contract 75
7.5.3 Jan 24, 2017: Mayo Clinic Selects Vizient as Its Performance Improvement Partner 76
7.5.4 Dec 29, 2016: Zynex General Update and November Orders 76
7.5.5 Oct 24, 2016: Medline Creates 200 New Jobs in Georgia and Invests $60 Million to Expand Manufacturing and Distribution 77
7.5.6 Sep 13, 2016: Zynex Announces August Orders 77
7.5.7 Aug 16, 2016: Zynex Announces July Orders 77
7.6 Strategy And Business Planning 78
7.6.1 Jul 21, 2017: Endo to Restructure Manufacturing Network 78
8 Appendix 79
8.1 Research Methodology 80
8.1.1 Coverage 80
8.1.2 Secondary Research 80
8.1.3 Primary Research 81
8.1.4 Company Share Analysis 81
8.1.5 Distribution Share Analysis 81
8.1.6 Benchmarking 82
8.2 GlobalData Consulting 82
8.3 Contact Us 83
8.4 Disclaimer 83
1.1 List of Tables
Table 1: Incontinence Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 9
Table 2: Incontinence Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 11
Table 3: Protective Garments for Incontinence Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 13
Table 4: Urinary Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 15
Table 5: Protective Garments for Incontinence Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 17
Table 6: Urinary Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Table 7: Incontinence Devices Market, United States, Volume (Units), Historic, 2009-2016 21
Table 8: Incontinence Devices Market, United States, Volume (Units), Forecast, 2016-2023 23
Table 9: Protective Garments for Incontinence Market, United States, Volume (Units), Historic, 2009-2016 25
Table 10: Urinary Catheters Market, United States, Volume (Units), Historic, 2009-2016 27
Table 11: Protective Garments for Incontinence Market, United States, Volume (Units), Forecast, 2016-2023 29
Table 12: Urinary Catheters Market, United States, Volume (Units), Forecast, 2016-2023 31
Table 13: Incontinence Devices Market, United States, Average Price ($), Historic, 2009-2016 32
Table 14: Incontinence Devices Market, United States, Average Price ($), Forecast, 2016-2023 33
Table 15: Incontinence Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 34
Table 16: Incontinence Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 36
Table 17: Incontinence Devices Market Pipeline Products 40
Table 18: Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 41
Table 19: Ethicon Acquires Torax Medical 43
Table 20: Zynex to Raise USD1.5 Million in Private Placement 44
Table 21: ConvaTec Raises USD1.8 Billion in IPO 45
Table 22: Consortia Health Raises USD2 Million in Financing 47
Table 23: Vesiflo Raises USD3.3 Million in Venture Financing 48
1.2 List of Figures
Figure 1: Incontinence Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 8
Figure 2: Incontinence Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 10
Figure 3: Protective Garments for Incontinence Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 12
Figure 4: Urinary Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 14
Figure 5: Protective Garments for Incontinence Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 16
Figure 6: Urinary Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Figure 7: Incontinence Devices Market, United States, Volume (Units), Historic, 2009-2016 20
Figure 8: Incontinence Devices Market, United States, Volume (Units), Forecast, 2016-2023 22
Figure 9: Protective Garments for Incontinence Market, United States, Volume (Units), Historic, 2009-2016 24
Figure 10: Urinary Catheters Market, United States, Volume (Units), Historic, 2009-2016 26
Figure 11: Protective Garments for Incontinence Market, United States, Volume (Units), Forecast, 2016-2023 28
Figure 12: Urinary Catheters Market, United States, Volume (Units), Forecast, 2016-2023 30
Figure 13: Incontinence Devices Market, United States, Company Share (%) 2016 35

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report